Filing Details

Accession Number:
0001179110-16-024408
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-05-12 16:07:39
Reporting Period:
2016-05-10
Filing Date:
2016-05-12
Accepted Time:
2016-05-12 16:07:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1235007 Endocyte Inc ECYT Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1509669 S Philip Low 3000 Kent Ave, Suite A1-100
West Lafayette IN 47906
Chief Science Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-05-10 11,566 $0.00 206,606 No 4 G Direct
Common Stock Acquisiton 2016-05-10 11,375 $3.52 217,981 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 G Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 193,318 Indirect By spouse trust
Footnotes
  1. Represents the purchase of 11,375 shares in multiple transactions, ranging in price from $3.46 to $3.56 per share, resulting in a weighted average purchase price per share of $3.52. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price within the range.